Medtronic plc, the global leader in medical technology, has announced the launch of the Medtronic MedTech Innovation Accelerator in Pujiang International Science and Technology City at Minhang District, Shanghai.

The new collaborative innovation platform will provide services for MedTech startups worldwide, address unmet clinical needs in China, and welcome its initial roster of portfolio companies. Through this new accelerator, Medtronic is committed to empowering early-stage MedTech innovations that aim to improve patient outcomes and convert ideas into valuable medical products and solutions.

The Medtronic MedTech Innovation Accelerator will also contribute to Shanghai's goal to become a science and technology innovation hub with global influence. It has received endorsement from the Minhang District government of Shanghai as well as one of the city's primary state-owned investment groups, Lingang Economic Development (Group) Co., Ltd.

The Lingang Group promises to provide subsidies and other policy incentives for the Medtronic MedTech Innovation Accelerator portfolio companies in addition to the world-class R&D resources and commercialization capabilities that Medtronic offers.